Merck KGaA (OTCPK:MKKGY)
$ 37.14 -0.0499 (-0.13%) Market Cap: 80.74 Bil Enterprise Value: 88.87 Bil PE Ratio: 27.43 PB Ratio: 2.67 GF Score: 93/100

Q4 2022 Merck KGaA Earnings Call Transcript

Mar 02, 2023 / 01:00PM GMT
Release Date Price: $38.08 (+0.82%)
Operator

Dear ladies and gentlemen, welcome to the Merck Investor and Analyst Conference Call on the Fourth Quarter 2022. (Operator Instructions)

I am now handing over to Constantin Fest, Head of Investor Relations, who will lead you through this conference. Please go ahead, sir.

Constantin Fest;Belen
MERCK Kommanditgesellschaft auf Aktien - Head of IR

Thank you, Sharon. A very warm welcome, dear ladies and gentlemen, to this Q4 Merck Earnings Release Call. My name is Constantin Fest. I'm the Head of Investor Relations here at Merck. And I'm delighted to be joined today by Belen Garijo, Group CEO; as well as Marcus Kuhnert, Group CFO, who will both lead us through the key slides of this presentation. We are also joined by our three sector CEOs: Matthias Heinzel, CEO of Life Science; Peter Guenter, CEO of Healthcare; as well as Kai Beckmann, CEO of Electronics. After the presentation, we will have some time for questions and answer.

And with this, I'd like to now hand over to Belen to kick off this presentation. Over to you, Belen.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot